{"id":449255,"title":"Table 1: Application of this Guidance to API Manufacturing : Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients: ICH Topic Q7A - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T18:40:26.086000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/legislation-regulatory-amendments/table-1-application-guidance-manufacturing-industry.html?wbdisable=false","snippet":"Table 1: Application of this Guidance to API Manufacturing : Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients: ICH Topic Q7A Table 1: Application of this Guidance to API Manufacturing Type of Manufacturing Application of this Guidance to steps Table 1…","rawSnapshotUrl":"/api/snapshots/raw/449255","browseUrl":"https://replay.healtharchive.ca/job-6/20260103184026/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/legislation-regulatory-amendments/table-1-application-guidance-manufacturing-industry.html?wbdisable=false#ha_snapshot=449255","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}